February 10, 2025|
AI
|10 months agoSwiss Pharma Industry Faces Potential Impact from US Trade Policies
UBS study warns of Swiss pharmaceutical sector's vulnerability to potential US tariffs, with possible long-term implications for research and production locations.
AI
Generated IllustrationKey Takeaways
AI
- Swiss pharmaceutical exports to US account for 60% of all goods exported from Switzerland to US
- Swiss companies employ 300,000-400,000 people in the United States
- UBS forecasts 1.5% economic growth for Switzerland despite trade tensions
- Trade balance between US and Switzerland is nearly equalized when including services
By The Numbers
60%
Share of Swiss pharmaceutical exports in total goods exports to US
1.5%
Projected Swiss economic growth
300,000-400,000
Number of US employees in Swiss companies
They Said
"Such a relocation would have a significant impact on Switzerland in terms of value creation and tax revenues"
"The effect of higher prices is likely to be minimal for luxury watches, as demand is relatively price inelastic"